PPCB vs ZBRA · P/E 0.0, $3.9M cap vs P/E 28, rev $3.05B
Propanc Biopharma, Inc. Common Stock (PPCB) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
PPCB does not have a complete income-statement cache yet.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
PPCB currently screens at market cap $3.9M and trailing P/E 0.0. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the PPCB and ZBRA stock pages for the full models.
Not investment advice.